Immunotherapy plus targeted radiation for advanced cancer
Treatments studied
Part of Cancer, Digestive system, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study tests whether combining immunotherapy (which boosts your immune system) with a precise, high-dose radiation treatment called SBRT can help people with advanced cancer live longer. It is for patients with at least 6 tumors that have spread, and aims to see if this treatment shrinks tumors and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced or stage IV cancer of the head, neck, lung, cervix, stomach, or esophagus.
- You have at least 6 tumors that have spread to other parts of the body (e.g., lung, liver, bone, or lymph nodes).
- You are eligible for immunotherapy (a type of treatment that helps your immune system fight cancer).
- You have not had chemotherapy or radiation within the last 21 days (unless it was for brain tumors, then you can start sooner).
- You are generally able to do daily activities (performance status 0 or 1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination for people whose head and neck cancer has come back after prior radiation. You'll receive an immunotherapy drug (pembrolizumab) plus radiation, then surgery. The goal is to see if this approach can improve how well surgery works.
This study tests whether adding focused radiation therapy to immunotherapy can help patients with advanced non-small cell lung cancer whose cancer has progressed despite prior immunotherapy. The goal is to see if this combination works better than immunotherapy alone.
This trial tests whether giving high-precision radiation to a few spots that are growing during immunotherapy (with or without chemotherapy) can help people with advanced lung cancer. It aims to see if treating these limited areas of resistance can extend the time the cancer stays under control.
This trial tests whether combining radiation therapy with immunotherapy works better than immunotherapy alone for advanced head and neck cancer that hasn't been treated before. The goal is to help your body's immune system fight the cancer more effectively.
This study tests giving a short course of targeted radiation (SBRT) along with immunotherapy and a targeted drug before surgery for advanced head and neck cancer. The goal is to see if this combination can shrink the tumor and improve outcomes.
This trial studies whether a more intensive form of targeted radiation, combined with immunotherapy (immune checkpoint inhibitors), can work better and be safe for people with advanced non-small cell lung cancer. You may be considered if your tumor is limited in size and you’re able to receive both treatments.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.